MX9800239A - Metodos para el tratamiento y prevencion de diabetes. - Google Patents

Metodos para el tratamiento y prevencion de diabetes.

Info

Publication number
MX9800239A
MX9800239A MX9800239A MX9800239A MX9800239A MX 9800239 A MX9800239 A MX 9800239A MX 9800239 A MX9800239 A MX 9800239A MX 9800239 A MX9800239 A MX 9800239A MX 9800239 A MX9800239 A MX 9800239A
Authority
MX
Mexico
Prior art keywords
diabetes
prevention
treatment
methods
peptides
Prior art date
Application number
MX9800239A
Other languages
English (en)
Inventor
Marco Londei
G Leslie R David
Paul J Conlon
Nicholas Ling
Amitabh Gaur
Original Assignee
Neurocrine Biosciences Inc Ken
Inst Of Rheumatology
St Bartholomew S Hospital Ct
For Clinical Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc Ken, Inst Of Rheumatology, St Bartholomew S Hospital Ct, For Clinical Res filed Critical Neurocrine Biosciences Inc Ken
Publication of MX9800239A publication Critical patent/MX9800239A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Los péptidos y análogos de péptidos de la isoforma de 65KD de descarboxilasa de ácido glutámico, para utilizarse en el tratamiento y prevencion de diabetes. Los análogos de péptidos contienen generalmente de uno a tres alteraciones de aminoácidos. Los péptidos y análogos pueden utilizarse para diagnosticar diabetes y detectar una predisposicion a diabetes.
MX9800239A 1995-06-23 1998-01-07 Metodos para el tratamiento y prevencion de diabetes. MX9800239A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/494,624 US5945401A (en) 1995-06-23 1995-06-23 Peptide analogues of the 65KD isoform of human glutamic acid decarboxylase and uses thereof

Publications (1)

Publication Number Publication Date
MX9800239A true MX9800239A (es) 1998-11-29

Family

ID=23965258

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800239A MX9800239A (es) 1995-06-23 1998-01-07 Metodos para el tratamiento y prevencion de diabetes.

Country Status (7)

Country Link
US (1) US5945401A (es)
EP (1) EP0871657A1 (es)
JP (1) JPH11514847A (es)
AU (1) AU6478696A (es)
CA (1) CA2225406A1 (es)
MX (1) MX9800239A (es)
WO (1) WO1997000891A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1512004E (pt) * 2002-06-11 2006-08-31 Merck Patent Gmbh Metodo para mapear e eliminar epitopos para celulas t
KR20050071565A (ko) 2002-10-10 2005-07-07 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 지방 알콜의 염기성 에스테르 및 이들의 항염증제 또는면역조절제로서의 용도
EP1848806A4 (en) * 2005-02-04 2009-09-09 Dow Agrosciences Llc ANTI-T CELL AND AUTOANTIGEN TREATMENT OF AN AUTOIMMUNE DISEASE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041380A (en) * 1982-08-04 1991-08-20 La Jolla Cancer Research Foundation Tetrapeptide
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
US5547847A (en) * 1993-09-07 1996-08-20 University Of Washington Diagnosis of insulin-dependent diabetes

Also Published As

Publication number Publication date
WO1997000891A1 (en) 1997-01-09
US5945401A (en) 1999-08-31
AU6478696A (en) 1997-01-22
EP0871657A1 (en) 1998-10-21
JPH11514847A (ja) 1999-12-21
CA2225406A1 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
DE69431060D1 (de) Klonierte glutaminsäure-decarboxylase
ES2007418A6 (es) Procedimiento para preparar un derivado azucar de un peptido biologicamente activo.
EP0726706A4 (en) N, N 'DISUBSTITUTED GUANIDINES AND THEIR USE AS EXCITATOR AMINO ACID ANTAGONISTS
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
NZ315809A (en) Opiate tetrapeptides with a tyr (or 2',6'-dimethyl tyr) at one terminus and an optionally substituted amino at the other terminus
ES2160485A1 (es) Peptidos inhibidores de la exorcitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
PL312989A1 (en) Therapeutic derivatives of peptides
HUP9800727A3 (en) Thrombin inhibitors based on the amino acid sequence of hirudin
TW364850B (en) Nematocidal compositions
CA2153789A1 (en) Biologically active tgf-.beta.1 and tgf-.beta.2 peptides
HK1030551A1 (en) Antimicrobial peptides
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
EP0366638A3 (en) Neuromodulatory peptide
PL321091A1 (en) Analogues of peptide p@&& and pharmaceutic sets of components containing them, used in treatment or diagnosis of diabetes
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
UA32523C2 (uk) Пептиди, які мають високу біологічну активність, та фармацевтична композиція на їх основі
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
MY124560A (en) Amino acid compositions and use thereof in immunosuppression
GR852541B (es)
MX9800239A (es) Metodos para el tratamiento y prevencion de diabetes.
EP0264953A3 (en) Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use
EP0783524A4 (en) PEPTIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0688319A4 (en) 4-HYDROXY-3-NITRO-1,2-DIHYDROQUINOLIN-2-ONES AND THEIR USE AS ANTIAGONISTS OF RECEPTOR AMINO ACID EXCITATORS AND GLYCINE
GB9224684D0 (en) Rheumatoid arthritis treatment